-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Guardant Health, Raises Price Target to $180

Benzinga·08/03/2026 11:54:14
Listen to the news
Stifel analyst Daniel Arias maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $130 to $180.